文献速递慢性肾脏病

尿酸轨迹预测慢性肾脏病不良结局:轨迹分析的新见解

Uric acid predicts adverse outcomes in chronic kidney disease: a novel insight from trajectory analyses.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

本研究基于13年前瞻性多学科pre-ESRD登记队列,纳入5090例20-90岁CKD患者,采用基于组的轨迹模型将血清尿酸轨迹分为高、中高、中、低四组,发现 elevated SUA轨迹与ESRD及全因死亡风险呈剂量反应关系升高,且未用降尿酸药者ESRD风险更高。

要点

  • SUA轨迹升高与ESRD风险呈剂量反应关系,高轨迹组aHR 2.84。
  • 高SUA轨迹组全因死亡aHR 4.52,中高轨迹组aHR 1.95。
  • 未用降尿酸药者SUA轨迹对ESRD的不良效应更显著(交互P=0.018)。

核心结论

  • 升高的SUA轨迹与CKD患者加速进展至肾衰竭及全因死亡相关。
  • 需充分实验证据指导该人群SUA优化时机与方式。

研究设计与样本

  • 前瞻性队列研究,来自13年多学科pre-ESRD照护登记。
  • 最终纳入5090例20-90岁CKD患者(2003-2015年)。
  • 采用基于组的轨迹模型定义SUA轨迹为高、中高、中、低四组。
  • 用多 Cox 回归分析至ESRD和死亡时间。

主要发现

  • 共发生948例ESRD事件和472例死亡,发病率分别为57.9和28.7/1000人年。
  • 调整后ESRD风险(vs 低轨迹):中轨迹aHR 1.89(95%CI 1.37-2.60),中高轨迹2.49(1.75-3.55),高轨迹2.84(1.81-4.47)。
  • 全因死亡风险(vs 低轨迹):中轨迹aHR 1.38(95%CI 0.89-2.12),中高轨迹1.95(1.22-3.10),高轨迹4.52(2.48-8.26)。
  • 未用降尿酸药者SUA轨迹对ESRD的不良效应更高(交互P=0.018)。

临床怎么用

  • 对CKD患者可考虑纵向监测SUA轨迹以识别ESRD和死亡高风险者。
  • 未使用降尿酸药的患者中,SUA轨迹升高对ESRD风险提示更强。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Very little is known about longitudinal trajectories of serum uric acid (SUA) over the course of chronic kidney disease (CKD). We aimed to determine whether longitudinal SUA trajectories are associated with the risk of end-stage renal disease (ESRD) and all-cause mortality among CKD patients. METHODS: We conducted a prospective cohort study from a 13-year multidisciplinary pre-ESRD care registry. The final study population consisted of 5090 CKD patients aged 20-90 years between 2003 and 2015. An individual's SUA trajectory was defined by group-based trajectory modeling in four distinct patterns: high, moderate-high, moderate and low. Time to ESRD and death was analyzed by multiple Cox regression. RESULTS: A total of 948 ESRD events and 472 deaths occurred with incidence rates of 57.9 and 28.7 per 1000 person-years, respectively. Compared with those with a low SUA trajectory, the adjusted hazard ratio of patients for incident ESRD was in a dose-response manner as follows: moderate, 1.89 [95% confidence interval (CI), 1.37-2.60]; moderate-high, 2.49 (1.75-3.55); and high, 2.84 (1.81-4.47); after considering the competing risk of death. For all-cause mortality, the corresponding risk estimate of the same SUA trajectory was 1.38 (95% CI, 0.89-2.12), 1.95 (1.22-3.10) and 4.52 (2.48-8.26), respectively. The unfavorable effect of elevated SUA trajectories on progression to ESRD was differentially higher among CKD patients without using urate-lowering agents at baseline (P for interaction = 0.018). CONCLUSIONS: Elevated SUA trajectories are associated with accelerated kidney failure and all-cause mortality in CKD patients. Adequate experimental evidence is urgently needed to inform when and how to optimize SUA in this population.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Tsai CW, Chiu HT, Huang HC, et al. Uric acid predicts adverse outcomes in chronic kidney disease: a novel insight from trajectory analyses. Nephrol Dial Transplant. 2018. PMID: 29140472. doi:10.1093/ndt/gfx297

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。